Top compounds associated with response to LGALS9B


Feature Type Standardized
Nominal ANOVA
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.027 0.5
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.027 0.5
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA CIL55A CTRPv2 pan-cancer AAC -0.036 0.5
mRNA pluripotin CTRPv2 pan-cancer AAC 0.024 0.5
mRNA MK-0752 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC -0.032 0.5
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.5
mRNA necrostatin-1 CTRPv2 pan-cancer AAC -0.025 0.5
Download CSV